HCC
CELG

Hirtle Callaghan & Co’s Celgene Corp CELG Stock Holding History

Hirtle Callaghan & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,600
Closed -$515K – 497
2014
Q4 		$515K Buy
4,600
+3,800
+475% +$401K 0.12% 111
2014
Q3 		$76K Buy
800
+400
+100% +$36.1K 0.01% 267
2014
Q2 		$34K Hold
400
– – ﹤0.01% 407
2014
Q1 		$28K Buy
+400
New +$31.7K ﹤0.01% 426

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hirtle Callaghan & Co's CELG Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Celgene Corp (CELG) in Q1 2015, closing a stake of 4,600 shares — an estimated $515K sold.

Hirtle Callaghan & Co first reported a position in CELG in Q1 2014 and held it in 4 quarters. The position peaked at $515K in Q4 2014. 1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining Celgene Corp position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 4,600 Celgene Corp shares in Q1 2015, an estimated $515K.
  • Hirtle Callaghan & Co first reported a position in Celgene Corp in Q1 2014 and held it in 4 quarters.
  • Hirtle Callaghan & Co's Celgene Corp position peaked at $515K in Q4 2014.
  • 1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.